Picture of LadRx logo

LADX LadRx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for LadRx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-7.52-6.7-13.2-4.20.4
Depreciation
Non-Cash Items1.670.32800.0110
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.110.2040.854-0.6580.602
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-5.72-6.14-12.3-4.831.01
Capital Expenditures-0.025-0.026-0.007-0.0010
Purchase of Fixed Assets
Other Investing Cash Flow Items0.5
Sale of Fixed Assets
Cash from Investing Activities0.475-0.026-0.007-0.0010
Financing Cash Flow Items09.180
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities00.0399.08-0.561-0.319
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5.24-6.13-3.23-5.390.695